Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

74.11
-1.2400-1.65%
Pre-market: 74.560.4500+0.61%07:21 EDT
Volume:1.42M
Turnover:105.44M
Market Cap:10.30B
PE:-10.32
High:74.89
Open:74.31
Low:73.52
Close:75.35
52wk High:88.31
52wk Low:47.22
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.87
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-59.39
PE(LYR):-11.33

Loading ...

Cytokinetics Schedules Q2 Earnings Release, Conference Call

Reuters
·
Jul 24

Cytokinetics to Announce Second Quarter Results on August 6, 2026

THOMSON REUTERS
·
Jul 24

Cytokinetics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 18

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 18

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 16

Cytokinetics CEO Robert I. Blum Disposes of 7,500 Common Shares for $615,150

Reuters
·
Jul 15

How Myqorzo’s US and German Launches Will Impact Cytokinetics (CYTK) Investors

Simply Wall St.
·
Jul 12

Larimar, Cytokinetics, Itau, Global-e, Immunovant Shake-Up

TIPRANKS
·
Jul 11

High-Profile Insider Trade Shakes Up Cytokinetics Watchlist

TIPRANKS
·
Jul 08

Cytokinetics EVP R&D Malik Fady Ibraham Disposes of 3,500 Common Shares Worth $303,170

Reuters
·
Jul 08

Cytokinetics is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 08

RBC Capital Adjusts Cytokinetics Price Target to $117 From $119, Maintains Outperform Rating

MT Newswires Live
·
Jul 07

Cytokinetics Releases ESC 2026 Late-breaking Abstracts Update

Reuters
·
Jul 07

Cytokinetics Announces Three Late-breaking Science Abstracts at the European Society of Cardiology (esc) Congress 2026

THOMSON REUTERS
·
Jul 07

Cytokinetics Announces Three Late-Breaking Science Abstracts at the European Society of Cardiology (ESC) Congress 2026

GlobeNewswire
·
Jul 07

CYTK, PRME, DOCS, WBD, LQDA Trending With Analysts

TIPRANKS
·
Jul 04

Top Cytokinetics Insiders Quietly Cash In With Major Stock Sales

TIPRANKS
·
Jul 03

Cytokinetics CFO Sung Lee Disposes of 1,112 Common Shares for $97,618.48

Reuters
·
Jul 03

Cytokinetics CFO Lee Sung Reports Sale of 3,134 Common Shares Valued at $266,390

Reuters
·
Jun 30

Cytokinetics Seen Gaining From Myqorzo Momentum to Treat Heart Conditions, UBS Says

MT Newswires Live
·
Jun 30